Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Soy protein has been investigated for its potential benefits in supporting bone health and preventing or treating osteoporosis, primarily due to its content of isoflavones—phytoestrogens that are structurally similar to human estrogen. Estrogen plays a critical role in maintaining bone density, and its decline during menopause is a key contributor to osteoporosis in women. Clinical studies and meta-analyses have produced mixed but generally modest results. Some randomized controlled trials suggest that soy isoflavones may slow bone loss or modestly increase bone mineral density (BMD) in postmenopausal women compared to placebo. However, the magnitude of these effects is generally small, and not all studies have found statistically significant benefits. Reviews by organizations such as the Cochrane Collaboration and meta-analyses published in peer-reviewed journals generally conclude that while there may be a slight positive effect, the evidence is not strong enough to recommend soy protein or isoflavone supplementation as a primary therapy for osteoporosis. The mechanism is hypothesized to involve estrogen receptor modulation and possible effects on calcium absorption. In summary, soy protein has a scientific rationale and some supporting evidence for use in osteoporosis, but the overall strength of the evidence is limited, and it should not be considered a replacement for established osteoporosis treatments.

More about Soy Protein
More about Osteoporosis

Other ingredients used for Osteoporosis

Other health conditions supported by Soy Protein

Products containing Soy Protein